Showing results (431-440 of 468) with videos related to
Sort By:
Pageof 47
ACS Nano|June 18, 2024
Unveiling Trends: Nanoscale Materials Shaping Emerging Biomedical ApplicationsKevin J Hughes, Jianjun Cheng, Kavita A Iyer, et al.Nature Communications|May 23, 2022
The unconventional activation of the muscarinic acetylcholine receptor M4R by diverse ligandsJingjing Wang, Meng Wu, Zhangcheng Chen, et al.Journal of Medicinal Chemistry|April 1, 2022
Long Residence Time at the Vasopressin V2 Receptor Translates into Superior Inhibitory Effects in Ex Vivo and In Vivo Models of Autosomal Dominant Polycystic Kidney DiseaseHaoran Zhang, Wenzhong Yan, Yongzhan Sun, et al.Zhongguo Shi Yan Xue Ye Xue Za Zhi|June 29, 2012
[Clinical analysis of 12 cases of acute myeloid leukemia with Ph chromosome and BCR-ABL positive]Xin-Hong Fei, Shu-Lan Wu, Rui-Juan Sun, et al.Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|February 17, 2012
[Cytomegalovirus enteritis after allogeneic hematopoietic stem cell transplantation]Yu-Ming Yin, Tong Wu, Shu-Quan Ji, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|March 6, 2026
A systematic approach to develop and characterize a compositionally equivalent buprenorphine in situ forming implant (Sublocade®)Surendra Poudel, Rudra Pangeni, Ziyu Huo, et al.Biophysics Reports|March 27, 2018
Identification of natural products as novel ligands for the human 5-HT2C receptorYao Peng, Simeng Zhao, Yiran Wu, et al.Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|December 3, 2010
[Successful treatment of high risk/refractory leukemia by tumor-ablative individualized conditioning allogeneic hematopoietic stem cell transplantation]Jing-Bo Wang, Wan-Ming DA, Jian-Ping Zhang, et al.Proceedings of the National Academy of Sciences of the United States of America|May 2, 2019
Reprogramming the microenvironment with tumor-selective angiotensin blockers enhances cancer immunotherapyVikash P Chauhan, Ivy X Chen, Rong Tong, et al.Journal of Medicinal Chemistry|January 31, 2015
Optimization of 2-phenylcyclopropylmethylamines as selective serotonin 2C receptor agonists and their evaluation as potential antipsychotic agentsJianjun Cheng, Patrick M Giguère, Oluseye K Onajole, et al.Pageof 47